-
Mashup Score: 0Intravesical Erdafitinib (TAR-210) Demonstrates High Response Rates in NMIBC With Reduced Toxicity - Roger Li - 52 minute(s) ago
Sam Chang engages with Roger Li to delve into the TAR-210 study, focusing on bladder-based intravesical therapy targeting FGFR3 in non-muscle invasive bladder cancer (NMIBC) patients. Dr. Li shares insights from the multi-site international study, highlighting the efficacy of Erdafitinib, particularly in patients with FGFR alterations. Despite the challenges with oral Erdafitinib’s toxicity, the…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0Researchers identify connection between air pollutants and allergic diseases - 53 minute(s) ago
A study by researchers at National Jewish Health published in the Annals of Allergy, Asthma & Immunology reports that air pollutants—including particulate matter, pollen, greenhouse gases, and …
Source: medicalxpress.comCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 0Developing transmissible vaccines for animal infections - 53 minute(s) ago
Intrinsically safe designs and a staged transparent development process will be essential
Source: www.science.orgCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 04 employment contract red flags young physicians should watch for - 53 minute(s) ago
Young physicians are not usually well-versed in contract law. One AMA expert outlines some points to avoid in the physician employment contract.
Source: www.ama-assn.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0SCOTUS to hear arguments on whether emergency care law preempts state abortion ban - 53 minute(s) ago
The Supreme Court will hear oral arguments tomorrow morning in a case highlighting the clash between federal emergency care requirements and state laws banning abortion services. | The top court will hear from the Department of Justice and the state of Idaho on how EMTALA requirements may or may not conflict with state abortion bans and whether the federal emergency care law was meant to apply to abortion care.
Source: www.fiercehealthcare.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 04 Years In, a Sobering Look at Long COVID Progress - 53 minute(s) ago
Long COVID is still a disease diagnosed by figuring out what a patient does not have. Symptom management is the only treatment now.
Source: www.mdedge.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0'Heat is on' cross-market hospital merger oversight: researchers - 55 minute(s) ago
Health systems that purchased hospitals at least 50 miles away increased prices by 12.9% relative to a control group, new research shows.
Source: www.modernhealthcare.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0VIDEO: What physicians should know about diagnosing chronic diarrhea - 55 minute(s) ago
BOSTON — Chronic diarrhea is an “incredibly common” condition, with about one out of 20 patients presenting with symptoms, according to Brian E. Lacy, MD, PhD, FACG, a professor of medicine at the Mayo Clinic.At the ACP Internal Medicine Meeting, Lacy explained that the first step in diagnosing chronic diarrhea is distinguishing it from acute diarrhea. While acute diarrhea lasts
Source: www.healio.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Immunotherapy Safely Boosted with Particle-Bound Cytokines in Tumor Models - 57 minute(s) ago
Used in combination with immune checkpoint therapy, cytokine molecules “step on the gas” to jump-start the immune system’s anticancer response.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 2Initiation of Statins for Primary Prevention in HFpEF - American College of Cardiology - 58 minute(s) ago
Dustin D Spencer, PharmD
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
Intravesical erdafitinib demonstrates high response rates in #NMIBC with reduced toxicity. @UrogerliMD and @UroCancerMD discuss the #TAR210, share insights, and highlight the efficacy of Erdafitinib, particularly in patients with FGFR alterations > https://t.co/6TS98s21us https://t.co/htHlfaY15j